Quantcast
Channel: WN.com - Articles related to Actelion to enter Phase II clinical development with new dual orexin receptor antagonist in patients with insomnia (Actelion Ltd)
Viewing all articles
Browse latest Browse all 480

Mount Kilimanjaro trek looks for answers to heart and lung disease (Griffith University)

$
0
0
(Source: Griffith University) Griffith Professor Norm Morris will join a medical research expedition to climb Mount Kilimanjaro in a bid to better understand pulmonary hypertension and heart failure by measuring the effects of increased altitude. A key feature of the pulmonary hypertension is a marked decrease in exercise tolerance and an increased shortness of breath on mild exertion, similar to what mountain climbers experience at high altitude. Pulmonary hypertension occurs when the pressure of the blood travelling between the heart and...

Viewing all articles
Browse latest Browse all 480

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>